Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003045 · ClinicalTrials.gov registry record · NA
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00003045 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 38 participants.
The verdict
NCT00003045, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Hyperthermia therapy may kill prostate cancer cells by heating them to several degrees above body temperature. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining hyperthermia with radiation therapy may kill more tumor cells. The purpose of this study is to determine the ability of hyperthermia when combined with radiation therapy and in some patients hormonal therapy to control prostate cancer.
Interventions
- RADIATION XRT
- DEVICE Hyperthermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 1997-04 |
| Est. Completion | 2003-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003045
The ClinicalTrials.gov registry entry for NCT00003045 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which XRT is the first listed.
NCT00003045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003045 about?
NCT00003045 is a clinical study titled "Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer". Hyperthermia therapy may kill prostate cancer cells by heating them to several degrees above body temperature. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining hyperthermia with radiation therapy may kill more tumor cells. The purpose of this study is to determine the abil...
What is the current status of trial NCT00003045?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 1997-04. Estimated completion is 2003-12-31.
What interventions are being tested in trial NCT00003045?
The interventions under investigation include: XRT (RADIATION), Hyperthermia (DEVICE).
Who is sponsoring clinical trial NCT00003045?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.